Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Laurus Labs gets 3 USFDA observations for Visakhapatnam facility

      Laurus Labs gets 3 USFDA observations for Visakhapatnam facility

      Medical Dialogues Bureau22 Nov 2019 12:08 PM IST
      The inspection of Visakhapatnam facility in Andhra Pradesh was completed with three observations, 'which are procedural in nature'. No data integrity...
      Zydus Cadila Desonide Cream, Isosorbide Dinitrate tablets get USFDA approval

      Zydus Cadila Desonide Cream, Isosorbide Dinitrate tablets get USFDA approval

      Medical Dialogues Bureau22 Nov 2019 11:55 AM IST
      Zydus Cadila has received approval from the US Food and Drug Administration (USFDA) for Isosorbide Dinitrate tablets for preventing attacks of chest...
      Alnylams rare genetic disorder drug gets early U.S. approval

      Alnylam's rare genetic disorder drug gets early U.S. approval

      Medical Dialogues Bureau21 Nov 2019 12:54 PM IST
      Alnylam Pharmaceuticals Inc on Wednesday received an early U.S. approval for its gene silencing drug to treat patients with a rare genetic disorder...
      Charity to pay $4 million to resolve U.S. pharma kickback probe

      Charity to pay $4 million to resolve U.S. pharma kickback probe

      Medical Dialogues Bureau21 Nov 2019 12:53 PM IST
      BOSTON - A Florida-based charity will pay $4 million to resolve claims that it acted as a conduit for companies including Biogen Inc and Novartis AG...
      China plans to add more drugs to price-slashing bulk-buy program

      China plans to add more drugs to price-slashing bulk-buy program

      Medical Dialogues Bureau21 Nov 2019 12:51 PM IST
      BEIJING: China will add more drugs to its bulk-buy program in an effort to curb high medicine prices, the country's cabinet said, in a move that could...
      Fake doctors, misleading claims drive OxyContin China sales

      Fake doctors, misleading claims drive OxyContin China sales

      Medical Dialogues Bureau21 Nov 2019 12:19 PM IST
      SHANGHAI: The Sackler family's opioid empire in the United States is collapsing under an avalanche of litigation over marketing tactics. Their Purdue...
      With questions about safety of Merils Made in India BVS stent, NPPA defers its appeal for price exemption

      With questions about safety of Meril's Made in India BVS stent, NPPA defers its appeal for price exemption

      Medical Dialogues Bureau21 Nov 2019 12:09 PM IST
      New Delhi: With an industry association raising health and safety concerns about the flagship Sirolimus-Eluting BioResorbable vascular scaffold system...
      China to launch inspection on production, sale, use of illegal African swine fever vaccines

      China to launch inspection on production, sale, use of illegal African swine fever vaccines

      Medical Dialogues Bureau21 Nov 2019 9:00 AM IST
      The ministry has previously warned against the use of such products, after reports of both imported and homemade products being used in China.BEIJING:...
      FIRST: Dr Reddys forays into nutrition segment with launch of diabetes drink Celevida in India

      FIRST: Dr Reddys forays into nutrition segment with launch of diabetes drink Celevida in India

      Medical Dialogues Bureau20 Nov 2019 12:28 PM IST
      M V Ramana, Chief Executive Officer, Branded Markets (India and Emerging Markets), Dr Reddy’s Laboratories said, “We are pleased to mark our foray...
      Knowledge sharing from 2019 World Conference on Access to Medical Products to be utilized for larger public welfare: Dr Harsh Vardhan

      Knowledge sharing from 2019 World Conference on Access to Medical Products to be utilized for larger public welfare: Dr Harsh Vardhan

      Medical Dialogues Bureau20 Nov 2019 11:00 AM IST
      The Union Health Minister, Dr Harsh Vardhan stated, “this conference will spur innovative thinking around issues surrounding provisioning of...
      Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

      Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

      Medical Dialogues Bureau20 Nov 2019 9:30 AM IST
      Suven Life Sciences provides contract research and manufacturing services to global life sciences companies. It plans to invest 75 million dollars...
      Panacea Biotec appoints Rajeeva Kumar Mangalum as Chief Operating Officer for pharmaceutical operations

      Panacea Biotec appoints Rajeeva Kumar Mangalum as Chief Operating Officer for pharmaceutical operations

      Medical Dialogues Bureau20 Nov 2019 9:15 AM IST
      Panacea Biotec announced the elevation of Rajeeva Kumar Mangalum as Chief Operating Officer for the pharmaceutical operations and Dinesh Singla as...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok